SecBot SecBot
144 ·Filed Jun 22, 2026

RYTM

RHYTHM PHARMACEUTICALS, INC.
NEUTRAL
Impact 2/10
Horizonimmediate Processed4mo ago SEC0001950047-26-006392
Form 144, notice of proposed sale of securities
Actionable Insight • Neutral

Routine 10b5-1 plan sale by a director with no material signal. Monitor for future insider filings to detect any sustained selling pattern.

DirectionNeutral
Confidencehigh
Horizonimmediate

How the stock moved after the report

NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60
Entry
$106.19
T+0 close · Jun 22, 2026 · via day close
Latest settled
−7.70%
T+60 · $98.01
Vs SPY
−10.95%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Jun 23 $106.19entry
  2. T+1 · 5mo ago +1.28%α +1.33% · $107.55
  3. T+5 · 5mo ago +3.63%α +2.61% · $110.04
  4. T+20 · 4mo ago −1.50%α −2.66% · $104.60
  5. T+60 · 2mo ago −7.70%α −10.95% · $98.01
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Director Lynn Tetrault filed a Form 144 to sell 37,000 shares via option exercise, valued at approximately $3.58 million, under a 10b5-1 plan adopted on 12/15/2025. The sale is small relative to the company's $6.6B market cap and represents routine insider diversification with no material read-through for the stock.

Key Facts

  • Director Lynn Tetrault intends to sell 37,000 shares of common stock.
  • Estimated proceeds of $3,581,230 (based on filing price).
  • Sale is pursuant to a 10b5-1 plan adopted on 12/15/2025.
  • Sale date is 06/22/2026, same day as filing.
  • Sale represents approximately 0.05% of RYTM's $6.6B market cap.

Financial Impact

Director sale of ~$3.58M; 0.05% of market cap.

Risk Factors

  • Minimal, no material risk to stock from this filing alone.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
91% bullish (22 analysts)

Investment Themes

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
144 Filing (Primary)0001950047-26-006392
Document: 0001950047-26-006392-index.html0001950047-26-006392
Document: 0001950047-26-006392.txt0001950047-26-006392

Track record

26 reports on RYTM

Performance horizon

9 of 14 bullish or bearish reports moved the stock their way by T+5. Best: +32.06% at T+60 after the May 1, 2026 report. 11 of 14 went positive at some point.

Filters
  1. Nov 16, 2026today Press Release Bullish 5/10 Entry $107.48 Now $107.48 +0.00% settles Nov 24
  2. Nov 4, 202612d ago Institutional Cluster Neutral 3/10 Entry $110.68 to $112.16 Now $107.48 −2.89% ▲ +1.34% +2.25% vs SPY
  3. Nov 4, 202612d ago Press Release Bullish 5/10 Entry $110.68 to $112.16 Now $107.48 −2.89% ▲ +1.34% +2.25% vs SPY
  4. Nov 3, 202613d ago 8-K Bullish 6/10 No price data
  5. Nov 3, 202613d ago Press Release Bullish 6/10 Entry $86.44 to $113.95 Now $107.48 +24.34% ▲ +31.83% +32.41% vs SPY
  6. Nov 2, 202614d ago Press Release Neutral 5/10 Entry $86.44 to $113.95 Now $107.48 +24.34% ▲ +31.83% +32.41% vs SPY
  7. Oct 13, 20264w ago Press Release Bullish 6/10 Entry $86.71 to $88.62 Now $107.48 +23.95% ▲ +2.20% +1.75% vs SPY
  8. Oct 13, 20264w ago SC 13G Neutral 3/10 Entry $86.61 to $90.20 Now $107.48 +24.10% ▲ +4.14% +5.30% vs SPY
  9. Sep 14, 20269w ago 144 Bearish 5/10 Entry $96.77 to $99.27 Now $107.48 −11.07% ▼ −2.58% −0.47% vs SPY
  10. Aug 17, 202613w ago Insider Cluster Bearish 6/10 Entry $115.25 to $113.35 Now $107.48 +6.74% ▲ +1.65% +1.45% vs SPY
Showing 10 of 26

US Market Status

Market Closed · Opens Wed (11h 3m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jun 22, 2026